雌激素及其受体在病理性疼痛中的作用机制

doi:10.12114/j.issn.1007-9572.2023.0377

摘要/Abstract

摘要： 病理性疼痛是一种严重的慢性疾病，包括炎症性疼痛、神经病理性疼痛和癌性疼痛。大量研究证实，雌激素及其受体与病理性疼痛之间密切相关，对其发生和发展有着不可忽视的作用。结合近几年国内外相关文献，本文阐述了雌激素及其受体在病理性疼痛中作用机制的相关研究进展，旨在为病理性疼痛的防治和治疗提供理论依据并指导未来研究方向。

关键词: 雌激素, 雌激素受体, 炎症性疼痛, 神经病理性疼痛, 癌性疼痛

Abstract:

Pathologic pain is a serious chronic disease, including inflammatory pain, neuropathic pain and cancer pain. Previous studies have proved a close correlation of estrogen and its receptors with pathologic pain, which plays an important role in its occurrence and development, therefore, it has attracted the attention of many researchers at home and abroad. Combining the relevant literature at home and abroad in recent years, this paper reviews the relevant research progress of the mechanism of estrogen and its receptors in pathologic pain, in order to provide a theoretical basis for the prevention and treatment of pathologic pain, as well as the guidance for future research.

Key words: Estrogens, Estrogen receptor, Inflammatory pain, Neuropathic pain, Cancer pain

中图分类号:

R 441.1

何帮靖,周明旺,张朋威. 雌激素及其受体在病理性疼痛中的作用机制[J]. 中国全科医学, 2024, 27(33): 4204-4209. DOI: 10.12114/j.issn.1007-9572.2023.0377.
HE Bangjing,ZHOU Mingwang,ZHANG Pengwei. Mechanism of Estrogen and Estrogen Receptors in Pathologic Pain[J]. Chinese General Practice, 2024, 27(33): 4204-4209. DOI: 10.12114/j.issn.1007-9572.2023.0377.

参考文献 54

[1]	宋学军，樊碧发，万有，等. 国际疼痛学会新版疼痛定义修订简析[J]. 中国疼痛医学杂志，2020，26（9）：641-644. DOI：10.3969/j.issn.1006-9852.2020.09.001.
[2]	ZHANG W X，WU H，XU Q，et al. Estrogen modulation of pain perception with a novel 17β-estradiol pretreatment regime in ovariectomized rats[J]. Biol Sex Differ，2020，11（1）：2. DOI：10.1186/s13293-019-0271-5.
[3]	LI L L，FAN X T，WARNER M，et al. Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice[J]. Pain，2009，143（1/2）：37-40. DOI：10.1016/j.pain.2009.01.005.
[4]	张雨桐，王姿雯，杜佳蓉，等. 雌激素参与慢性痛的性别差异[J]. 中国疼痛医学杂志，2018，24（7）：536-541. DOI：10.3969/j.issn.1006-9852.2018.07.012
[5]	LABASTIDA-RAMÍREZ A，RUBIO-BELTRÁN E，VILLALÓN C M，et al. Gender aspects of CGRP in migraine[J]. Cephalalgia，2019，39（3）：435-444. DOI：10.1177/0333102417739584.
[6]	SALDANHA C J，DUNCAN K A，WALTERS B J. Neuroprotective actions of brain aromatase[J]. Front Neuroendocrinol，2009，30（2）：106-118. DOI：10.1016/j.yfrne.2009.04.016.
[7]	SANTEN R J，SIMPSON E. History of estrogen: its purification，structure，synthesis，biologic actions，and clinical implications[J]. Endocrinology，2019，160（3）：605-625. DOI：10.1210/en.2018-00529.
[8]	LU H，OZAWA H，NISHI M，et al. Serotonergic neurones in the dorsal raphe nucleus that project into the medial preoptic area contain oestrogen receptor beta[J]. J Neuroendocrinol，2001，13（10）：839-845. DOI：10.1046/j.1365-2826.2001.00695.x.
[9]	ALEXANDER S P，CHRISTOPOULOS A，DAVENPORT A P，et al. The concise guide to pharmacology 2021/22：g protein-coupled receptors[J]. Br J Pharmacol，2021，178（Suppl 1）：S27-156. DOI：10.1111/bph.15538.
[10]	XU Z Z，XIE W L，FENG Y Q，et al. Positive interaction between GPER and β-alanine in the dorsal root ganglion uncovers potential mechanisms: mediating continuous neuronal sensitization and neuroinflammation responses in neuropathic pain[J]. J Neuroinflammation，2022，19（1）：164. DOI：10.1186/s12974-022-02524-9.
[11]	SHANG X S，ZHANG L R，JIN R L，et al. Estrogen regulation of the expression of pain factor NGF in rat chondrocytes[J]. J Pain Res，2021（14）：931-940. DOI：10.2147/JPR.S297442.
[12]	GOROWSKA-WOJTOWICZ E，DULIBAN M，KOTULA-BALAK M，et al. Modulatory effects of estradiol and its mixtures with ligands of GPER and PPAR on MAPK and PI3K/Akt signaling pathways and tumorigenic factors in mouse testis explants and mouse tumor leydig cells[J]. Biomedicines，2022，10（6）：1390. DOI：10.3390/biomedicines10061390.
[13]	JIANG N，AN J Y，YANG K，et al. NLRP3 inflammasome：a new target for prevention and control of osteoporosis?[J]. Front Endocrinol （Lausanne），2021，12：752546. DOI：10.3389/fendo.2021.752546.
[14]	DRAGIN N，NANCY P，VILLEGAS J，et al. Balance between estrogens and proinflammatory cytokines regulates chemokine production involved in thymic germinal center formation[J]. Sci Rep，2017，7（1）：7970. DOI：10.1038/s41598-017-08631-5.
[15]	WU X B，CAO D L，ZHANG X，et al. CXCL13/CXCR5 enhances sodium channel Nav1.8 current density via p38 MAP kinase in primary sensory neurons following inflammatory pain[J]. Sci Rep，2016，6：34836. DOI：10.1038/srep34836.
[16]	SONG X X，JIN L Y，LI X F，et al. Substance P mediates estrogen modulation proinflammatory cytokines release in intervertebral disc[J]. Inflammation，2021，44（2）：506-517. DOI：10.1007/s10753-020-01347-1.
[17]	JI J，HE Q R，LUO X，et al. IL-23 enhances C-fiber-mediated and blue light-induced spontaneous pain in female mice[J]. Front Immunol，2021，12：787565. DOI：10.3389/fimmu.2021.787565.
[18]	王芷，宋小星，张富军. 雌激素调控去势小鼠疼痛的炎症机制[J]. 上海交通大学学报（医学版），2017，37（7）：936-941. DOI：10.3969/j.issn.1674-8115.2017.07.009
[19]	POHÓCZKY K，KUN J，SZALONTAI B，et al. Estrogen-dependent up-regulation of TRPA1 and TRPV1 receptor proteins in the rat endometrium[J]. J Mol Endocrinol，2016，56（2）：135-149. DOI：10.1530/JME-15-0184.
[20]	KAUR S，MCDONALD H，TONGKHUYA S，et al. Estrogen exacerbates the nociceptive effects of peripheral serotonin on rat trigeminal sensory neurons[J]. Neurobiol Pain，2021，10：100073. DOI：10.1016/j.ynpai.2021.100073.
[21]	GU Y，ZHANG N X，ZHU S J，et al. Estradiol reduced 5-HT reuptake by downregulating the gene expression of Plasma Membrane Monoamine Transporter （PMAT，Slc29a4） through estrogen receptor β and the MAPK/ERK signaling pathway[J]. Eur J Pharmacol，2022，924：174939. DOI：10.1016/j.ejphar.2022.174939.
[22]	MA W，ST-JACQUES B，RUDAKOU U，et al. Stimulating TRPV1 externalization and synthesis in dorsal root ganglion neurons contributes to PGE2 potentiation of TRPV1 activity and nociceptor sensitization[J]. Eur J Pain，2017，21（4）：575-593. DOI：10.1002/ejp.959.
[23]	COLLOCA L，LUDMAN T，BOUHASSIRA D，et al. Neuropathic pain[J]. Nat Rev Dis Primers，2017，3：17002. DOI：10.1038/nrdp.2017.2.
[24]	MEACHAM K，SHEPHERD A，MOHAPATRA D P，et al. Neuropathic pain：central vs. peripheral mechanisms[J]. Curr Pain Headache Rep，2017，21（6）：28. DOI：10.1007/s11916-017-0629-5.
[25]	XU Z Z，CHEN Q Y，DENG S Y，et al. 17β-estradiol attenuates neuropathic pain caused by spared nerve injury by upregulating CIC-3 in the dorsal root ganglion of ovariectomized rats[J]. Front Neurosci，2019，13：1205. DOI：10.3389/fnins.2019.01205.
[26]	DENG C，GU Y J，ZHANG H，et al. Estrogen affects neuropathic pain through upregulating N-methyl-D-aspartate acid receptor 1 expression in the dorsal root ganglion of rats[J]. Neural Regen Res，2017，12（3）：464-469. DOI：10.4103/1673-5374.202925.
[27]	MA J N，MCFARLAND K，OLSSON R，et al. Estrogen receptor beta selective agonists as agents to treat chemotherapeutic-induced neuropathic pain[J]. ACS Chem Neurosci，2016，7（9）：1180-1187. DOI：10.1021/acschemneuro.6b00183.
[28]	NADERI A，ASGARI A R，ZAHED R，et al. Estradiol attenuates spinal cord injury-related central pain by decreasing glutamate levels in thalamic VPL nucleus in male rats[J]. Metab Brain Dis，2014，29（3）：763-770. DOI：10.1007/s11011-014-9570-z.
[29]	GUO W，MIYOSHI K，DUBNER R，et al. Spinal 5-HT3 receptors mediate descending facilitation and contribute to behavioral hypersensitivity via a reciprocal neuron-glial signaling cascade[J]. Mol Pain，2014，10：35. DOI：10.1186/1744-8069-10-35.
[30]	KAUR S，HICKMAN T M，LOPEZ-RAMIREZ A，et al. Estrogen modulation of the pronociceptive effects of serotonin on female rat trigeminal sensory neurons is timing dependent and dosage dependent and requires estrogen receptor alpha[J]. Pain，2022，163（8）：e899-916. DOI：10.1097/j.pain.0000000000002604.
[31]	CHEN J H，SUN Y，JU P J，et al. Estrogen augmented visceral pain and colonic neuron modulation in a double-hit model of prenatal and adult stress[J]. World J Gastroenterol，2021，27（30）：5060-5075. DOI：10.3748/wjg.v27.i30.5060.
[32]	ZHOU L J，YANG T，WEI X，et al. Brain-derived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat[J]. Brain Behav Immun，2011，25（2）：322-334. DOI：10.1016/j.bbi.2010.09.025.
[33]	IMLACH W L，BHOLA R F，MOHAMMADI S A，et al. Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain[J]. Sci Rep，2016，6：37104. DOI：10.1038/srep37104.
[34]	LYU C，MULDER J，BARDE S，et al. G protein-gated inwardly rectifying potassium channel subunits 1 and 2 are down-regulated in rat dorsal root ganglion neurons and spinal cord after peripheral axotomy[J]. Mol Pain，2015，11：44. DOI：10.1186/s12990-015-0044-z.
[35]	DEFAZIO R A，NAVARRO M A，ADAMS C E，et al. Estradiol enhances the depolarizing response to GABA and AMPA synaptic conductances in arcuate kisspeptin neurons by diminishing voltage-gated potassium currents[J]. J Neurosci，2019，39（48）：9532-9545. DOI：10.1523/JNEUROSCI.0378-19.2019.
[36]	SALEM M L，HOSSAIN M S，NOMOTO K. Mediation of the immunomodulatory effect of beta-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-alpha and IFN-gamma[J]. Int Arch Allergy Immunol，2000，121（3）：235-245. DOI：10.1159/000024323.
[37]	LEE J Y，CHOI H Y，JU B G，et al. Estrogen alleviates neuropathic pain induced after spinal cord injury by inhibiting microglia and astrocyte activation[J]. Biochim Biophys Acta Mol Basis Dis，2018，1864（7）：2472-2480. DOI：10.1016/j.bbadis.2018.04.006.
[38]	刘艳敏，费以琳，黎星淼，等. 雌激素促进星形胶质细胞系U-87增殖和侵袭[J]. 基础医学与临床，2020，40（3）：305-309. DOI：10.3969/j.issn.1001-6325.2020.03.005.
[39]	ZAJĄCZKOWSKA R，KOCOT-KĘPSKA M，LEPPERT W，et al. Bone pain in cancer patients: mechanisms and current treatment[J]. Int J Mol Sci，2019，20（23）：6047. DOI：10.3390/ijms20236047.
[40]	YONEDA T，HIASA M，NAGATA Y，et al. Acidic microenvironment and bone pain in cancer-colonized bone[J]. Bonekey Rep，2015，4：690. DOI：10.1038/bonekey.2015.58.
[41]	YONEDA T，HIASA M，OKUI T，et al. Sensory nerves: A driver of the vicious cycle in bone metastasis?[J]. J Bone Oncol，2021，30：100387. DOI：10.1016/j.jbo.2021.100387.
[42]	QUAIL D F，JOYCE J A. Microenvironmental regulation of tumor progression and metastasis[J]. Nat Med，2013，19（11）：1423-1437. DOI：10.1038/nm.3394.
[43]	BARAL P，UDIT S，Chiu IM. Pain and immunity：implications for host defence[J]. Nat Rev Immunol，2019，19（7）：433-447. DOI：10.1038/s41577-019-0147-2.
[44]	LI Y，CAI J，HAN Y，et al. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain[J]. Eur J Pain，2014，18（6）：774-784. DOI：10.1002/j.1532-2149.2013.00420.x.
[45]	DE FRANCESCO E M，PELLEGRINO M，SANTOLLA M F，et al. GPER mediates activation of HIF1α/VEGF signaling by estrogens[J]. Cancer Res，2014，74（15）：4053-4064. DOI：10.1158/0008-5472.CAN-13-3590.
[46]	ZHANG Z L，DENG M L，HUANG J J，et al. Microglial annexin A3 downregulation alleviates bone cancer-induced pain through inhibiting the Hif-1α/vascular endothelial growth factor signaling pathway[J]. Pain，2020，161（12）：2750-2762. DOI：10.1097/j.pain.0000000000001962.
[47]	SMEESTER B A，O'BRIEN E E，MICHLITSCH K S，et al. The relationship of bone-tumor-induced spinal cord astrocyte activation and aromatase expression to mechanical hyperalgesia and cold hypersensitivity in intact female and ovariectomized mice[J]. Neuroscience，2016，324：344-354. DOI: 10.1016/j.neuroscience.2016.03.030.
[48]	XU M S，WANG Y，XIA R L，et al. Role of the CCL2-CCR2 signalling axis in cancer：mechanisms and therapeutic targeting[J]. Cell Prolif，2021，54（10）：e13115. DOI：10.1111/cpr.13115.
[49]	SHEN W，HU X M，LIU Y N，et al. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord[J]. J Neuroinflammation，2014，11：75. DOI：10.1186/1742-2094-11-75.
[50]	HE M，YU W W，CHANG C，et al. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways[J]. Mol Oncol，2020，14（8）：1779-1799. DOI：10.1002/1878-0261.12701.
[51]	LUO J，HUANG X X，LI Y L，et al. GPR30 disrupts the balance of GABAergic and glutamatergic transmission in the spinal cord driving to the development of bone cancer pain[J]. Oncotarget，2016，7（45）：73462-73472. DOI：10.18632/oncotarget.11867.
[52]	FRADET A，AOREL H，BOUAZZA L，et al. Dual function of ERRα in breast cancer and bone metastasis formation：implication of VEGF and osteoprotegerin[J]. Cancer Res，2011，71（17）：5728-5738. DOI：10.1158/0008-5472.
[53]	MATHILDE B，ALEXANDRA L，CYRIL B，et al. ERRα expression in bone metastases leads to an exacerbated antitumor immune response[J]. Cancer Res，2020，80（13）：2914-2926.
[54]	FRADET A，BOUCHET M，DELLIAUX C，et al. Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone[J]. Oncotarget，2016，7（47）：77071-77086. DOI：10.18632/oncotarget.12787.